Tissue Oxygen Saturation Clinical Trial
Official title:
Comparison of Change of Tissue Oxygenation During a Vascular Occlusion Test Using Two Different Near-infrared Spectroscopy (O3TM vs. INVOS®)
This study evaluates the change of tissue oxygenation during a vascular occlusion test using two NIRS ( O3TM and INVOS®). NIRS probe will be attached on volunteer's forearm during vascular occlusion test and tissue oxygenation change will be recorded
Near-infrared spectroscopy (NIRS) has been used to measure regional hemoglobin oxygen
saturation of tissue. Recently, it also has been used to monitor peripheral tissue oxygen
saturation, and micro-vascular reactivity using vascular occlusion test (VOT).
O3 TM is recently developed NIRS and there are only two clinical trials using this device,
until now. In one study, this device could adequately predict cerebral regional oxygen
saturation. And in the other study, peripheral tissue oxygenation was measured during
ischemic pre-conditioning in heart surgery and it showed correlation between O3 TM and other
NIRS ( EQUANOX) which has been used to monitor peripheral tissue oxygenation. But in this
study, study group was patient with heart disease and the deoxygenation and reoxygenation
rate during VOT was not not measured, which reflects tissue oxygen extraction and
micro-vascular reactivity.
In NIRS devices, there are assumed cerebral arterial-venous ratio upon which oximetry values
are calculated. In INVOS®, assumed arterial-venous ratio is 25/75. In other NIRS, assumed
arterial-venous ratio is 30/70. But unlike other NIRS, O3 TM can change its preset
arterial-venous ratio between 25/75 and 30/70, and there are no studies compare oximetry
values between these two different settings.
In this study, the investigators try to compare INVOS®, which has been used widely for
monitor tissue oxygenation, and two different settings of O3 TM ( arterial-venous ratio;
30/70 and 25/75). Three probes will be attached at same site simultaneously and the
investigators will measure change of tissue oxygenation, deoxygenation rate and reoxygenation
rate during vascular occlusion test
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02038062 -
Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery
|
N/A | |
| Completed |
NCT02034682 -
The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy
|
N/A |